Pharmacology and autoradiography of human DP prostanoid receptors using [3H]-BWA868C, a DP receptor-selective antagonist radioligand

British Journal of Pharmacology

Volumn 131, Issue 6, 2000, Pages 1025-1038

  Sharif, N A ^a   Williams, G W ^a   Davis, T L ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

DP antagonist; DP receptor; Human platelets; Prostaglandins; Receptor autoradiography

Indexed keywords

3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 9BETA CHLORO 15 CYCLOHEXYL 9 DEOXY 16,17,18,19,20 PENTANOR 3 OXAPROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTANOID DP RECEPTOR; PROSTANOID RECEPTOR; RADIOLIGAND; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CHOROID; CILIARY BODY EPITHELIUM; CILIARY MUSCLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; EYE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; THROMBOCYTE MEMBRANE;

EID: 0033695826     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703686     Document Type: Article

References (45)

1. Human prostanoid receptors: Cloning and characterization
2. Tips receptor and ion channel nomenclature supplement
3. Biological aspects of prostaglandins
4. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors
5. The isolation of prostaglandins
6. Molecular cloning and characterization of the human prostanoid DP receptor
7. Nonlinear regression using spreadsheets
8. 50) of an enzymatic reaction
9. Prostanoids and their receptors
10. VIII International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
11. 2 receptor
12. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: Pharmacological characterization using agonists and antagonists
13. 2- and IP-prostaglandin receptors in human ocular and other cell-types
14. Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology
15. Functional characterization of the DP receptor in human myometrium
16. 2
17. The classification of prostaglandin DP-receptors in platelets and vasculature using BWA868C, a novel, selective and potent competitive antagonist
18. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization
19. FP prostaglandin receptors mediating inositol phosphate generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study
20. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
21. 2 (DP) receptors: Estimation of affinities and relative efficacies for a series of novel bicyclic ligands with an appendix on goodness-of-fit analyses
22. Are there subtypes of prostaglandin DP receptors?
23. 2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats
24. 2 receptor is the predominant prostanoid receptor in the human ciliary muscle
25. A practical computer based approach to the analysis of radioligand binding experiments
26. Analysis of radioligand binding experiments on a microcomputing system
27. 2 binding protein from porcine temporal cortex
28. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
29. Prostanoid receptors: Structure, function, and distribution
30. Structure and function of prostanoid receptors
31. Interspecies differences in thromboxane receptors: Studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles
32. Effects of a selective DP receptor agonist (BW245C) and antagonist (BWA868C) on the canine colonic epithelium: An argument for a different DP receptor?
33. In vitro characterization of prostanoid receptors on human myometrlum at term pregnancy
34. Quantitative autoradiographic methods
35. 3H]9-β-[+]fluprostenol): Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor
36. Discrete mapping of brain mu and delta opioid receptors using selective peptides: Quantitative autoradiography, species differences and comparison with kappa receptors
37. Characterization of the ocular anti-allergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases
38. 3 and FP receptor binding sites in bovine corpus luteum: Characterization and correlation with functional data
39. 2 to rat brain synaptic membrane. Occurrence, properties and distribution
40. 2 in primary cultures of bovine adrenal medullary cells: Identification of the responsive population as fibroblasts
41. 2-receptor
42. 2 binding to synaptic membrane fraction of rat brain
43. 2 receptors
44. 2 and BW245C activation of human platelet adenylate cyclase
45. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist